Pacira Biosciences, Inc. (PCRX)
36.48
+0.02
(+0.05%)
USD |
NASDAQ |
Nov 16, 16:00
36.48
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Price : 36.48 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 36.48 | 36.49 | 36.48 | 36.48 | 1.806M |
| Nov 13, 2026 | 36.47 | 36.48 | 36.43 | 36.46 | 1.945M |
| Nov 12, 2026 | 36.48 | 36.49 | 36.46 | 36.46 | 804535.0 |
| Nov 11, 2026 | 36.48 | 36.50 | 36.45 | 36.46 | 945465.0 |
| Nov 10, 2026 | 36.47 | 36.50 | 36.45 | 36.49 | 1.877M |
| Nov 09, 2026 | 36.44 | 36.47 | 36.44 | 36.46 | 523016.0 |
| Nov 06, 2026 | 36.42 | 36.45 | 36.42 | 36.43 | 537093.0 |
| Nov 05, 2026 | 36.41 | 36.46 | 36.41 | 36.42 | 1.130M |
| Nov 04, 2026 | 36.41 | 36.45 | 36.38 | 36.40 | 2.421M |
| Nov 03, 2026 | 36.41 | 36.41 | 36.39 | 36.39 | 1.075M |
| Nov 02, 2026 | 36.40 | 36.40 | 36.38 | 36.40 | 810929.0 |
| Oct 30, 2026 | 36.40 | 36.43 | 36.38 | 36.39 | 737238.0 |
| Oct 29, 2026 | 36.39 | 36.40 | 36.36 | 36.39 | 618951.0 |
| Oct 28, 2026 | 36.38 | 36.40 | 36.35 | 36.39 | 914029.0 |
| Oct 27, 2026 | 36.38 | 36.42 | 36.38 | 36.40 | 471792.0 |
| Oct 26, 2026 | 36.38 | 36.45 | 36.36 | 36.38 | 607300.0 |
| Oct 23, 2026 | 36.33 | 36.42 | 36.33 | 36.42 | 574317.0 |
| Oct 22, 2026 | 36.38 | 36.40 | 36.31 | 36.34 | 1.051M |
| Oct 21, 2026 | 36.36 | 36.38 | 36.32 | 36.33 | 1.488M |
| Oct 20, 2026 | 36.39 | 36.42 | 36.33 | 36.38 | 1.048M |
| Oct 19, 2026 | 36.35 | 36.39 | 36.33 | 36.34 | 1.066M |
| Oct 16, 2026 | 36.38 | 36.39 | 36.32 | 36.34 | 960937.0 |
| Oct 15, 2026 | 36.39 | 36.66 | 36.31 | 36.33 | 2.064M |
| Oct 14, 2026 | 36.33 | 36.48 | 36.31 | 36.40 | 2.332M |
| Oct 13, 2026 | 36.35 | 36.35 | 36.30 | 36.31 | 2.222M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Viatris, Inc. | 20.74 |
| Organon & Co. | 13.90 |
| ANI Pharmaceuticals, Inc. | 70.89 |
| Corcept Therapeutics, Inc. | 69.22 |
| Veru, Inc. | 2.08 |
Price Related Metrics
| PE Ratio | 39.51 |
| PS Ratio | 2.025 |
| PEG Ratio | 0.3692 |
| Price to Book Value | 2.043 |
| Price to Free Cash Flow | 8.906 |
| Earnings Yield | 2.53% |
| Market Cap | 1.455B |
| PEGY Ratio | 0.3692 |
| Operating PE Ratio | 48.52 |
| Normalized PE Ratio | 43.28 |